Search Results 1-10 of 12353 for ���������������������������op������r���:za33���
Subjects will be randomized 1:1 to R-CHOP plus enzastaurin or R CHOP (plus placebo during induction). All subjects will receive up to 6 cycles (3 weeks per ...
The purpose of this trilal is to study a combination of neoadjuvant radiotherapy (RT), immunotherapy (pembrolizumab) and chemotherapy for lymph node-positive, ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to assess the patient's quality of life following the paravertebral block(s) day post-op, 3-day post-op, ...
... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...
About this study. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus ...
Covington, MF, Pizzitola VJ, Lorans R, Pockaj BA, Northfelt DW, Appleton ... Electronic Poster - The Post-Op Breast on the Chest: Recognizing and ... Deipolyi AR, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.